Search filters

List of works by Morten Nielsen

Adoptive cell therapy with tumor-infiltrating lymphocytes in patients with metastatic ovarian cancer: a pilot study

scientific article published on 26 September 2018

Adoptive cell therapy with tumor-infiltrating lymphocytes supported by checkpoint inhibition across multiple solid cancer types

scientific article published in October 2021

Coexisting Alterations of MHC Class I Antigen Presentation and IFNγ Signaling Mediate Acquired Resistance of Melanoma to Post–PD-1 Immunotherapy

scientific article published on 15 August 2022

Genetic polymorphisms in the cytochrome P450 system and efficacy of 5-hydroxytryptamine type 3 receptor antagonists for postoperative nausea and vomiting.

scientific article

Haplotype structure of the beta2-adrenergic receptor gene in 814 Danish Caucasian subjects and association with body mass index

scientific article published in January 2009

Identification of expressed and conserved human noncoding RNAs

scientific article published on 16 December 2013

In vitro 4-1BB stimulation promotes expansion of CD8+ tumor-infiltrating lymphocytes from various sarcoma subtypes

scientific article published on 29 May 2020

Qualitative Analysis of Tumor-Infiltrating Lymphocytes across Human Tumor Types Reveals a Higher Proportion of Bystander CD8+ T Cells in Non-Melanoma Cancers Compared to Melanoma

scientific article published on 12 November 2020

Rapid Identification of the Tumor-Specific Reactive TIL Repertoire Combined Detection of CD137, TNF, and IFNγ, Following Recognition of Autologous Tumor-Antigens

scientific article published in 2021

T cells isolated from patients with checkpoint inhibitor resistant-melanoma are functional and can mediate tumor regression.

scientific article published on 24 April 2018

The Gly16 Allele of the Gly16Arg Single-Nucleotide Polymorphism in the β₂-Adrenergic Receptor Gene Augments Perioperative Use of Vasopressors: A Retrospective Cohort Study

scientific article published on 14 January 2016

Transcriptomic signatures of tumors undergoing T cell attack

scientific article published on 17 July 2021